The preliminary outcome of the combination of immunotherapy and targeted therapy after recurrence and metastasis for hereditary leiomyomatosis and renal cell cancer—a case report

Hereditary leiomyomatosis and renal cell cancer (HLRCC)-associated kidney cancer is a rare and exceptionally aggressive, with early metastasis and die at a young age. Most reported patients usually present with back pain and hematuria, and died within 5 years after diagnosis. Currently, there is not...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Dechao, Yang, Yubo, Han, Ping, Wei, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215000/
https://www.ncbi.nlm.nih.gov/pubmed/32420185
http://dx.doi.org/10.21037/tau.2019.12.37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215000/
https://www.ncbi.nlm.nih.gov/pubmed/32420185
http://dx.doi.org/10.21037/tau.2019.12.37

Ejemplares similares